Avid runner, tattoo enthusiast, on occasion neuroscientist. The postings are my own and do not necessarily reflect the views of Scripps Research.

San Diego, CA
Joined June 2018
Postdoc position open to study the effects of alcohol/abused substances. Supported by our NIAAA T32. US citizens or permanent residents only. Individuals underrepresented in the field are encouraged to apply. Will attend CPDD and RSA in June 2024. Contact: [email protected]
1
2
237
Martin-Fardon Lab retweeted
Postdoc position available to investigate the effects of alcohol and other abused substances. Supported by our NIH/NIAAA T32. US citizens or permanent resident status is required. Individuals underrepresented in the field are encouraged to apply. Contact: [email protected]
4
7
797
Postdoc position available to investigate the effects of alcohol and other abused substances. Supported by our NIH/NIAAA T32. US citizens or permanent resident status is required. Individuals underrepresented in the field are encouraged to apply. Contact: [email protected]
4
7
797
Martin-Fardon Lab retweeted
A new Scripps Research study shows how an insomnia drug helps prevent oxycodone relapse, paving the way for new therapies. scripps.edu/news-and-events/…
1
8
2,793
Fantastic panel focusing on alcohol's effect on the CRF system outside the amygdala (!) Very cool work by Remi Martin-Fardon, @DrJRink Audrey Seasholtz and @superrsema and great moderating by @Marcus
1
2
2
32
3,662
Martin-Fardon Lab retweeted
Looking forward to chairing this symposium on CRF-alcohol interactions outside the amygdala with @superrsema at @RSAposts. Come by this Sunday at 1:20 if you can! (1/2) – at Grapevine, TX
1
3
1
29
3,072
Martin-Fardon Lab retweeted
My first postdoc paper from @giodeguglielmo’s is out! We looked at oxycodone effects in 4 rat strains (and both sexes) as part of a collaboration between @TeleseFrancesca, @brainaddiction, @FardonLab labs, and huge effort by lab manager @amaaartinez7 doi.org/10.1016/j.neuropharm…
1
11
1
24
4,830
Scientists in @FardonLab have shown in preclinical studies that the insomnia drug suvorexant is able to reduce prescription opioid intake and help protect against relapse in animals modeling opioid use disorder scripps.edu/news-and-events/…
1
3
1
9
6,663
In a new study by @FardonLab, the team show that the insomnia drug suvorexant, which blocks the activity of brain-cell receptors called orexin receptors, could be repurposed to help reduce voluntary alcohol intake and relapse scripps.edu/news-and-events/… @FrontiersIn
1
3
9
4,086
Proud to have our work highlighted by NIAAA @PatelReesha @Carolinja2 @Lorenzo__Leggio @dalleceelena @FardonLab @DrRgonzales @sophia_khom @NeuroDAmbrosio @Bamijo2002 Marisa Roberto, Luis Natividad, Hui Sun, Alessandra Matzeu, Sarah Wolfe, Pauravi Gandhi, Larry Rodriguez &Tony Kerr
This Post is from an account that no longer exists. Learn more
1
6
1
29